Brokerages Set STERIS plc (NYSE:STE) PT at $258.75

STERIS plc (NYSE:STE - Get Free Report) has received an average recommendation of "Moderate Buy" from the five ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $258.75.

Several research analysts have recently commented on the company. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a report on Monday, April 7th. Piper Sandler upped their price objective on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Stephens reaffirmed an "overweight" rating and set a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, April 10th.

Institutional Investors Weigh In On STERIS

Institutional investors and hedge funds have recently made changes to their positions in the stock. Avalon Trust Co bought a new stake in shares of STERIS during the 4th quarter worth approximately $30,000. Grove Bank & Trust raised its stake in shares of STERIS by 4,733.3% during the 1st quarter. Grove Bank & Trust now owns 145 shares of the medical equipment provider's stock worth $33,000 after purchasing an additional 142 shares in the last quarter. Human Investing LLC bought a new stake in shares of STERIS during the 4th quarter worth approximately $31,000. Anfield Capital Management LLC raised its stake in shares of STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 91 shares in the last quarter. Finally, ORG Wealth Partners LLC bought a new stake in shares of STERIS during the 1st quarter worth approximately $43,000. Institutional investors own 94.69% of the company's stock.

STERIS Stock Performance

STERIS stock traded down $1.71 during mid-day trading on Monday, reaching $223.03. The company had a trading volume of 540,687 shares, compared to its average volume of 534,074. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. STERIS has a 52 week low of $200.98 and a 52 week high of $248.24. The company has a 50 day moving average of $223.12 and a 200-day moving average of $218.91. The firm has a market cap of $21.91 billion, a price-to-earnings ratio of 47.35 and a beta of 0.87.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, sell-side analysts expect that STERIS will post 9.08 EPS for the current fiscal year.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.